Psoriasis: Targets and Therapy

Dove Medical Press

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Psoriasis: Targets and Therapy is an open-access journal published by Dove Medical Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,565 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Dove Medical Press
ISSN
2230-326X
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
3,565 USD
Articles in DOAJ
209
Declared review time
16 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2012-11-28
Indexing
DOAJ
APC
3,565 USD
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

209

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

220

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

34

i10-index

86

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2012-11-28
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSS
Editorial board
Official page ↗
Open references deposited at Crossref
75%
ORCID iDs in current deposits
85%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
Psoriasis, targets and therapyJournal of psoriasis
Source type
journal
NLM unique ID (PubMed)
101709086
Classification2

Subjects (DOAJ)

Medicine: Dermatology

LCC codes

RL1-803

Subject areas

  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Dermatology and Skin Diseases
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Dermatology and Skin Diseases
Show all subjects (75)
  • Dermatology and Skin Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Autoimmune Bullous Skin Diseases
  • Autoimmune Bullous Skin Diseases
  • Rheumatoid Arthritis Research and Therapies
  • Skin Diseases and Diabetes
  • Skin Diseases and Diabetes
  • Biological Research and Disease Studies
  • Biological Research and Disease Studies
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Cytokine Signaling Pathways and Interactions
  • Rheumatoid Arthritis Research and Therapies
  • Cytokine Signaling Pathways and Interactions
  • Skin Protection and Aging
  • Skin Protection and Aging
  • Autoimmune and Inflammatory Disorders Research
  • Autoimmune and Inflammatory Disorders Research
  • Asthma and respiratory diseases
  • Asthma and respiratory diseases
  • Skin and Cellular Biology Research
  • Skin and Cellular Biology Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Genetic Associations and Epidemiology
  • Health Systems, Economic Evaluations, Quality of Life
  • Bioinformatics and Genomic Networks
  • Bioinformatics and Genomic Networks
  • Nail Diseases and Treatments
  • Urticaria and Related Conditions
  • Therapeutic Uses of Natural Elements
  • Health Systems, Economic Evaluations, Quality of Life
  • Nail Diseases and Treatments
  • Urticaria and Related Conditions
  • Cutaneous lymphoproliferative disorders research
  • Liver Disease Diagnosis and Treatment
  • Advancements in Transdermal Drug Delivery
  • Therapeutic Uses of Natural Elements
  • Drug-Induced Adverse Reactions
  • Hidradenitis Suppurativa and Treatments
  • Drug-Induced Adverse Reactions
  • Hidradenitis Suppurativa and Treatments
  • Osteomyelitis and Bone Disorders Research
  • Skin Diseases and Diabetes
  • Medication Adherence and Compliance
  • Drug-Induced Adverse Reactions
  • Vitamin D Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • Vitamin D Research Studies
  • Immunodeficiency and Autoimmune Disorders
  • Genetic and rare skin diseases.
  • Systemic Lupus Erythematosus Research
  • Liver Disease Diagnosis and Treatment
  • Dermatological and COVID-19 studies
  • Liver Disease Diagnosis and Treatment
  • Hair Growth and Disorders
  • Herpesvirus Infections and Treatments
  • Adipokines, Inflammation, and Metabolic Diseases
  • Biosimilars and Bioanalytical Methods
  • Systemic Lupus Erythematosus Research
  • Skin and Cellular Biology Research
  • Lipoproteins and Cardiovascular Health
  • Gut microbiota and health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Smoking Behavior and Cessation
  • Vitamin D Research Studies

Keywords (DOAJ)

  • skin diseases
  • psoriasis
  • psoriatic arthritis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: